5AM Venture Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Hold |
736,595
| – | – | 3.96% | 9 |
|
|
2025
Q1 | $9.93M | Hold |
736,595
| – | – | 3.76% | 10 |
|
|
2024
Q4 | $14.1M | Hold |
736,595
| – | – | 3.37% | 11 |
|
|
2024
Q3 | $16.8M | Hold |
736,595
| – | – | 3.46% | 12 |
|
|
2024
Q2 | $9.58M | Hold |
736,595
| – | – | 2.14% | 15 |
|
|
2024
Q1 | $12.9M | Buy |
736,595
+150,000
| +26% | +$2.63M | 2.89% | 15 |
|
|
2023
Q4 | $12.8M | Buy |
586,595
+176,595
| +43% | +$3.85M | 3.39% | 11 |
|
|
2023
Q3 | $6.29M | Buy |
410,000
+130,000
| +46% | +$1.99M | 1.81% | 17 |
|
|
2023
Q2 | $6.66M | Hold |
280,000
| – | – | 1.66% | 18 |
|
|
2023
Q1 | $7.12M | Sell |
280,000
-20,000
| -7% | -$509K | 1.82% | 14 |
|
|
2022
Q4 | $8.76M | Sell |
300,000
-184,891
| -38% | -$5.4M | 2.35% | 15 |
|
|
2022
Q3 | $9.95M | Buy |
+484,891
| New | +$9.95M | 1.91% | 13 |
|